Alentis Therapeutics Company
Alentis Therapeutics is a biotech company focused on discovering and developing new medications to treat advanced liver diseases. They have a mission to treat cancer and reverse fibrosis by advancing their clinical pipeline of anti-Claudin-1 monoclonal antibodies. Their goal is to unlock the broad potential of their therapeutic target Claudin-1 and bring new treatments to patients.
Investors
Headquarters:
Basel
Industry:
PharmTech